# Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis

> **NCT04484870** · PHASE4 · COMPLETED · sponsor: **First People's Hospital of Hangzhou** · enrollment: 150 (actual)

## Conditions studied

- Choledocholithiasis
- Recurrence

## Interventions

- **DRUG:** oral Danshu capsule

## Key facts

- **NCT ID:** NCT04484870
- **Lead sponsor:** First People's Hospital of Hangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-07-30
- **Final completion:** 2019-07-20
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484870, "Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04484870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*